Global Cord Blood (NYSE:CO) and Allied Esports Entertainment (NASDAQ:AESE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.
Insider and Institutional Ownership
16.3% of Global Cord Blood shares are held by institutional investors. Comparatively, 8.8% of Allied Esports Entertainment shares are held by institutional investors. 22.0% of Allied Esports Entertainment shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
This table compares Global Cord Blood and Allied Esports Entertainment’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Global Cord Blood||$147.03 million||3.71||$43.38 million||N/A||N/A|
|Allied Esports Entertainment||N/A||N/A||$1.14 million||N/A||N/A|
Global Cord Blood has higher revenue and earnings than Allied Esports Entertainment.
This table compares Global Cord Blood and Allied Esports Entertainment’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Cord Blood||34.86%||10.88%||5.73%|
|Allied Esports Entertainment||N/A||-28.14%||-3.64%|
Volatility and Risk
Global Cord Blood has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Allied Esports Entertainment has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500.
This is a summary of recent ratings and price targets for Global Cord Blood and Allied Esports Entertainment, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Cord Blood||0||0||0||0||N/A|
|Allied Esports Entertainment||0||0||0||0||N/A|
Global Cord Blood beats Allied Esports Entertainment on 6 of the 8 factors compared between the two stocks.
About Global Cord Blood
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.